The Claim
In obese, nondiabetic women with a mean age of 48 ± 11 years and a baseline BMI of 33.1 ± 4.1 kg/m², short-term treatment with exenatide at a dose of 10 μg twice daily for 16 weeks results in an average weight loss of 2.49 kg compared to placebo, with significant weight reduction detectable within 2 weeks.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a drug called exenatide twice a day for about four months helps obese women who don’t have diabetes lose around 2.5 kilograms on average, and they start seeing results in just two weeks.
See the scientific wording
Short-term treatment with exenatide at a dose of 10 μg twice daily for 16 weeks causes an average weight loss of 2.49 kg in obese, nondiabetic women aged 48 ± 11 years with a baseline BMI of 33.1 ± 4.1 kg/m², compared to placebo, with significant weight reduction detectable within 2 weeks.
What the research says
1 studyThe study tested the exact same medicine and dose in similar women, and found they lost the same amount of weight, starting within 2 weeks, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.